Salvage cryotherapy for prostate cancer.
Arch Ital Urol Androl
; 95(4): 11897, 2024 Jan 08.
Article
in En
| MEDLINE
| ID: mdl-38193227
ABSTRACT
BACKGROUND:
Most men diagnosed with prostate cancer will be candidates for active treatment and 20 to 50% of patients treated with organ preserving strategies recur within the prostate. Optimal treatment of recurrence is controversial. Prostate cryosurgery has been increasingly used as primary, recurrence and focal treatment for prostate cancer.METHODS:
We analysed 55 patients submitted to cryotherapy as salvage treatment after recurrence.RESULTS:
Study population presented with a mean age of 70.9 ± 6.2 years, mean initial PSA of 7.6 ng/ml and average prostate volume by ultrasound of 43.2 ± 14.7 grams. Mean follow-up was of 18.0 months. Biochemical free survival at one year of follow-up was of 85%.CONCLUSIONS:
Cryotherapy can be an effective and safe treatment for recurrence after primary curative treatment failure.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Cryotherapy
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Arch Ital Urol Androl
Journal subject:
MEDICINA REPRODUTIVA
/
NEFROLOGIA
/
UROLOGIA
Year:
2024
Document type:
Article
Country of publication:
Italy